Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 12. Click on ID to see further detail.
IDOV_4607Virus nameAdenovirusVirus strainAd5/3-CB016Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 VP per cellIn-vitro result100% cell viablity after 3 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4608Virus nameAdenovirusVirus strainAd5/3-CB016Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration10 VP per cellIn-vitro result100% cell viablity after 3 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4609Virus nameAdenovirusVirus strainAd5/3-CB016Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration100 VP per cellIn-vitro result70% cell viablity after 3 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4610Virus nameAdenovirusVirus strainAd5/3-delata 24Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 and delta 24 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 VP per cellIn-vitro result100% cell viablity after 3 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4611Virus nameAdenovirusVirus strainAd5/3-delata 24Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 and delta 24 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration10 VP per cellIn-vitro result50% cell viablity after 3 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4612Virus nameAdenovirusVirus strainAd5/3-delata 24Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 and delta 24 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration100 VP per cellIn-vitro result10% cell viablity after 3 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4613Virus nameAdenovirusVirus strainAd5/3-CB016Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 VP per cellIn-vitro result70% cell viablity after 7 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4614Virus nameAdenovirusVirus strainAd5/3-CB016Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration10 VP per cellIn-vitro result58 cell viablity after 7 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4615Virus nameAdenovirusVirus strainAd5/3-CB016Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration100 VP per cellIn-vitro result10% cell viablity after 7 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4616Virus nameAdenovirusVirus strainAd5/3-delata 24Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 and delta 24 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration1 VP per cellIn-vitro result100% cell killing after 7 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4617Virus nameAdenovirusVirus strainAd5/3-delata 24Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 and delta 24 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration10 VP per cellIn-vitro result100% cell killing after 7 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483
IDOV_4618Virus nameAdenovirusVirus strainAd5/3-delata 24Virus genome typeDNAVirus familyAdenoviridaeVirus genome modificationMutation in delta E3 and delta 24 geneVirus aloneYesVirus in combination with drug/radiationNoImmune gene insertion in viral genomeNoSource of cell lineVU university medical centre, NetherlandOrigin of cell lineHuman neck and squamous cell carcinoma cell lineCell line93VU147TConcentration of cell line3000 cells per wellIn-vitro toxicityNAAssayMTT assayIn-vitro virus concentration100 VP per cellIn-vitro result100% cell killing after 7 daysModel organismNoIn-vivo virus concentrationNoIn-vivo toxicityNA In-vivo resultNo responseMode of deliveryNAPathway inducedNAImmunogenic effectNAClinical trialNAPMID27086483